
EnsoData Snags $20M to Improve Sleep Disorder Diagnostics
EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently.
EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently.
The genomic test, known as Oncotype DX, can help predict whether women with certain forms of breast cancer will benefit from chemotherapy -- and those who won't. The latest trial results extend the test's reach.
The company said the FDA gave it a 510(k) clearance for the use of Propeller, which combines sensors attached to inhalers with an app, with AstraZeneca's Symbicort, for patients with asthma and COPD.
With data-blocking rules expected to go into effect soon, patients should finally be able to access and freely share their health data. But should those rules also include privacy protections for those that opt to share their data with health apps?
David Van Sickle's eyes shine as he outlines the array of opportunities that have opened up ever since medical device maker ResMed acquired the Wisconsin startup in January 2019 for $225 million.
The companies tout the deal as expanding Exact's commercial footprint to 90 countries and creating a leader in the cancer diagnostic space with projected 2020 revenues of $1.6 billion.
Redox CEO Luke Bonney said the company saw more than 300 percent growth in its customer base over 2018 which led to the search of an investment partner to accelerate that momentum and help fund further product development.
Founded in 2013 and based in Madison, Wisconsin, HealthMyne offers a quantitative imaging decision support platform for radiology and oncology.
Bain Capital Ventures, Health X Ventures and Cultivation Capital led the funding round for the Madison, Wisconsin-based startup.
EBSCO Health, which is part of EBSCO Information Services, has acquired Wisconsin-based HealthDecision, a company offering tools to help clinicians and patients explore medical options.
Digital therapeutics company Propeller will continue to operate as a standalone business within ResMed's Respiratory Care portfolio.
In a phone interview, Propeller Health CEO David Van Sickle and CTO Greg Tracy discussed how their digital therapeutics company has evolved since its founding in 2010.
GE Healthcare is incorporating an AI-powered software imaging analysis tool in its Vscan ultrasound device for cardiac ultrasound developed by an Israeli company
The health system has joined forces with Foxconn Technology Group, Johnson Controls and Northwestern Mutual to create the $100 million Wisconn Valley Venture Fund, which will invest in startups in the healthcare, technology, manufacturing and financial services sectors.
Hospitals are energy hogs. But some are making efforts to become more energy-efficient, which can also boost the bottom line.